EDD number:
EDD-001
Description:
This determination authorises dealings with the genetically modified organism that comprises the vaccine for equine influenza which is marketed in the United States as ‘RECOMBITEK FLU’ and in Europe as ‘PROTEQFLU’ or ‘PROTEQFLU TE’ (the GMO).
GMO:
GM Canarypox virus modified for expression of equine influenza antigens
EDD start date:
EDD end date:
Related links: